TESAMORELIN+IPAMORELIN BLEND 13MG
SKU: CP_TESA_IPAMORELIN_13MG_3ML_VIAL
Catalog price · 1 item: US$140.00 (USD)
Product information
Compound background
The descriptive text identifies the tesamorelin component as a synthetic GHRH analogue acting through the GHRH receptor. It does not provide a separate mechanistic narrative for the ipamorelin component on this page.
Specifications
| SKU | CP_TESA_IPAMORELIN_13MG_3ML_VIAL |
|---|---|
| CATEGORY | Research Compound |
| CAS | N/A |
| VIAL SIZE | 3 mL |
| FORM | LYOPHILIZED POWDER |
| MOLECULAR WEIGHT | N/A |
| COMPOSITION | Tesamorelin 10 mg + Ipamorelin 3 mg |
| MOLECULAR FORMULA | N/A |
| ITEM ID | 101810 |
| PURITY | 99%+ |
| CAS | N/A |
| FORM | LYOPHILIZED POWDER |
| DOSAGE | 13 MG |
| CAS | 218949-48-5 |
| Formula | C221H366N72O67S |
| Mol. Wt. | 5135.9 g/mol |
| Sequence | trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2 |
| CAS | 170851-70-4 |
| Formula | C38H49N9O5 |
| Mol. Wt. | 711.85 g/mol |
| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2 |